HealthMore in Health→
DNA-Delivered Immunotherapy Shows Promise Against Ovarian Cancer
Key Takeaways
- Wistar researchers reported a preclinical ovarian cancer immunotherapy study in Molecular Therapy.
- The platform uses DNA delivery so the body can produce bispecific T cell engagers rather than relying only on conventional protein manufacturing.
- The approach also supports dual antigen targeting in a single dose, aimed at reducing tumor escape and resistance.
DE
DT Editorial Team··via medicalxpress.com